Mount Sinai
The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.
Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test
The ELISA-based test has shown 98.8 percent sensitivity and 99.6 percent specificity for detecting SARS-CoV-2 specific IgG against two virus antigens.
In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More
News items for the in vitro diagnostics industry for the week of Nov. 23, 2020.
Kantaro Biosciences, EKF Diagnostics Ink European Distribution Deal for SARS-CoV-2 Antibody Tests
Kantaro said that authorized clinical testing laboratories in Europe can use its enzyme-linked immunoassays, which detect IgG antibodies to two coronavirus antigens.